Effect of pimicotinib on tumor response and physical function (PF) by tumor location in patients with tenosynovial giant cell tumor (TGCT): Results from the phase 3 MANEUVER trial.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The University of Texas MD Anderson Cancer Center, Leiden University Medical Center, Abbisko Therapeutics Co., Ltd. (China), Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), Capital Medical University, Beijing Jishuitan Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck KGaA
OpenAlex ID: W7162507952
Cites:
Cited by:
Related to: